Opko Health Ownership

OPK Stock  USD 1.39  0.04  2.96%   
Opko Health owns a total of 793.05 Million outstanding shares. Opko Health has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Opko Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
For more information on how to buy Opko Stock please use our How to buy in Opko Stock guide.

Opko Stock Ownership Analysis

About 55.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.8. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Opko Health recorded a loss per share of 0.06. The entity had not issued any dividends in recent years. OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company was founded in 1991 and is headquartered in Miami, Florida. Opko Health operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 5767 people. To find out more about Opko Health contact Phillip Frost at (305) 575-4100 or learn more at https://www.opko.com.

Opko Health Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Opko Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on Opko Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Opko Health insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Yu Alice Lin-tsing over a week ago
Acquisition by Yu Alice Lin-tsing of 30000 shares of Opko Health at 1.47 subject to Rule 16b-3
 
Phillip Frost over three weeks ago
Acquisition by Phillip Frost of 125000 shares of Opko Health at 1.3577 subject to Rule 16b-3
 
Phillip Frost over three weeks ago
Acquisition by Phillip Frost of 125000 shares of Opko Health at 1.4772 subject to Rule 16b-3
 
Phillip Frost over a month ago
Acquisition by Phillip Frost of 100000 shares of Opko Health at 1.6485 subject to Rule 16b-3
 
Phillip Frost over a month ago
Acquisition by Phillip Frost of 1500000 shares of Opko Health at 0.8964 subject to Rule 16b-3
 
Phillip Frost over a month ago
Acquisition by Phillip Frost of 150000 shares of Opko Health at 1.6959 subject to Rule 16b-3
 
Phillip Frost over a month ago
Acquisition by Phillip Frost of 10101 shares of Opko Health at 1.265 subject to Rule 16b-3
 
Phillip Frost over two months ago
Acquisition by Phillip Frost of tradable shares of Opko Health at 1.15 subject to Rule 16b-3
 
Phillip Frost over three months ago
Acquisition by Phillip Frost of 47537 shares of Opko Health at 1.4738 subject to Rule 16b-3
 
Phillip Frost over three months ago
Acquisition by Phillip Frost of 150000 shares of Opko Health at 1.4695 subject to Rule 16b-3
 
Phillip Frost over three months ago
Acquisition by Phillip Frost of 500000 shares of Opko Health at 1.4817 subject to Rule 16b-3
 
Phillip Frost over three months ago
Acquisition by Phillip Frost of 100000 shares of Opko Health at 1.6198 subject to Rule 16b-3

Opko Health Outstanding Bonds

Opko Health issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Opko Health uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Opko bonds can be classified according to their maturity, which is the date when Opko Health has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Opko Health is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Opko Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Opko Health Stock. Highlighted below are key reports to facilitate an investment decision about Opko Health Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Opko Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
For more information on how to buy Opko Stock please use our How to buy in Opko Stock guide.
You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Opko Health. If investors know Opko will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Opko Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Opko Health is measured differently than its book value, which is the value of Opko that is recorded on the company's balance sheet. Investors also form their own opinion of Opko Health's value that differs from its market value or its book value, called intrinsic value, which is Opko Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Opko Health's market value can be influenced by many factors that don't directly affect Opko Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Opko Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Opko Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Opko Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.